Mitsubishi UFJ Asset Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $390K | Sell |
30,400
-685
| -2% | -$8.73K | ﹤0.01% | 891 |
|
|
2025
Q4 | $286K | Buy |
31,085
+3,944
| +15% | +$54.3K | ﹤0.01% | 965 |
|
|
2025
Q3 | $469K | Buy |
27,141
+49
| +0.2% | +$604 | ﹤0.01% | 878 |
|
|
2025
Q2 | $254K | Buy |
27,092
+5,634
| +26% | +$46.3K | ﹤0.01% | 945 |
|
|
2025
Q1 | $153K | Buy |
21,458
+4,165
| +24% | +$42.1K | ﹤0.01% | 987 |
|
|
2024
Q4 | $210K | Buy |
17,293
+6,972
| +68% | +$109K | ﹤0.01% | 983 |
|
|
2024
Q3 | $212K | Sell |
10,321
-966
| -9% | -$22.3K | ﹤0.01% | 957 |
|
|
2024
Q2 | $253K | Buy |
11,287
+3,438
| +44% | +$81.9K | ﹤0.01% | 934 |
|
|
2024
Q1 | $216K | Sell |
7,849
-355
| -4% | -$9.86K | ﹤0.01% | 956 |
|
|
2023
Q4 | $242K | Buy |
8,204
+1,553
| +23% | +$44.6K | ﹤0.01% | 990 |
|
|
2023
Q3 | $210K | Buy |
6,651
+451
| +7% | +$17.5K | ﹤0.01% | 1014 |
|
|
2023
Q2 | $253K | Buy |
6,200
+647
| +12% | +$26.2K | ﹤0.01% | 1008 |
|
|
2023
Q1 | $207K | Buy |
5,553
+401
| +8% | +$15.7K | ﹤0.01% | 1023 |
|
|
2022
Q4 | $179K | Sell |
5,152
-130
| -2% | -$6.18K | ﹤0.01% | 1034 |
|
|
2022
Q3 | $296K | Buy |
5,282
+286
| +6% | +$17.7K | ﹤0.01% | 977 |
|
|
2022
Q2 | $259K | Buy |
4,996
+2,724
| +120% | +$138K | ﹤0.01% | 1014 |
|
|
2022
Q1 | $165K | Buy |
2,272
+140
| +7% | +$11.9K | ﹤0.01% | 1082 |
|
|
2021
Q4 | $254K | Sell |
2,132
-2,601
| -55% | -$326K | ﹤0.01% | 1042 |
|
|
2021
Q3 | $635K | Buy |
4,733
+3
| +0.1% | +$454 | ﹤0.01% | 902 |
|
|
2021
Q2 | $766K | Sell |
4,730
-5,670
| -55% | -$442K | ﹤0.01% | 892 |
|
|
2021
Q1 | $835K | Buy |
10,400
+3,374
| +48% | +$226K | 0.01% | 817 |
|
|
2020
Q4 | $382K | Sell |
7,026
-2,912
| -29% | -$106K | ﹤0.01% | 862 |
|
|
2020
Q3 | $198K | Buy |
9,938
+121
| +1% | +$2.52K | ﹤0.01% | 898 |
|
|
2020
Q2 | $206K | Sell |
9,817
-2,085
| -18% | -$35.4K | ﹤0.01% | 890 |
|
|
2020
Q1 | $146K | Buy |
11,902
+2,392
| +25% | +$32.2K | ﹤0.01% | 890 |
|
|
2019
Q4 | $139K | Sell |
9,510
-43
| -0.5% | -$598 | ﹤0.01% | 923 |
|
|
2019
Q3 | $128K | Buy |
9,553
+1,859
| +24% | +$29.6K | ﹤0.01% | 878 |
|
|
2019
Q2 | $126K | Sell |
7,694
-1,216
| -14% | -$19.1K | ﹤0.01% | 895 |
|
|
2019
Q1 | $152K | Buy |
8,910
+529
| +6% | +$7.89K | ﹤0.01% | 829 |
|
|
2018
Q4 | $110K | Buy |
8,381
+2,892
| +53% | +$53.8K | ﹤0.01% | 836 |
|
|
2018
Q3 | $157K | Buy |
+5,489
| New | +$160K | ﹤0.01% | 797 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
